Bearish flow noted in Akero Therapeutics with 7,531 puts trading, or 3x expected. Most active are Nov-23 45 puts and Nov-23 35 puts, with total volume in those strikes near 6,700 contracts. The Put/Call Ratio is 18.92, while ATM IV is up nearly 3 points on the day. Earnings are expected on November 3rd.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See the top stocks recommended by analysts >>
Read More on AKRO:
- Akero Therapeutics to Present at the H.C. Wainwright 7th Annual NASH Virtual Investor Conference
- Akero Therapeutics selloff on data an overreaction, says H.C. Wainwright
- 89bio price target lowered to $27 from $34 at RBC Capital
- Akero Therapeutics price target lowered to $36 from $60 at Evercore ISI
- 89bio price target lowered to $29 from $49 at Evercore ISI
